Plant molecular farming: Host systems, technology and products

Applications of Plant Metabolic Engineering

Volumn 9781402060311, Issue , 2007, Pages 45-77

  Kumar, G B Sunil ^a   Ganapathi, T R ^a   Srinivas, L ^a   Bapat, V A ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Antibodies; Glycosylation; Hepatitis B; Host systems; Molecular farming; Recombinant proteins; Vaccines

Indexed keywords

ANTIBODIES; GLYCOSYLATION; MOLECULAR BIOLOGY; VACCINES;

AGROINFILTRATION; COMMERCIALIZED PRODUCTS; EXPRESSION SYSTEM; HEPATITIS B; MOLECULAR FARMING; NUCLEAR TRANSFORMATIONS; PRESCRIPTION DRUGS; TRANSIENT EXPRESSION;

RECOMBINANT PROTEINS;

EID: 39149135457     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4020-6031-1_2     Document Type: Chapter

References (144)

1. Bakker H, Bardor M, Molthoff JW et al. (2001) Galactose-extended glycans of antibodies produced by transgenic plants, Proc Natl Acad Sci USA. 98:2899-2904
2. Bardor M, Faveeuw C, Fitchette AC et al. (2003a) Immunoreactivity in mammals of two typical plant glyco-epitopes, core alpha 1, 3-fucose and core xylose, Glycobiology 13:427-434
3. Bardor M, Loutelier-Bourhis C, Paccalet T et al. (2003b) Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is suitable for glyco-engineering into humancompatible structures. Plant Biotechnol J 1:451-462
4. Barta A, Sommergruber K, Thomson D et al. (1986) The expression of a nopaline synthase-human growth hormone chimeric gene in transformed tobacco and sunflower callus tissue. Plant Mol Biol 6:347-357
5. Baur A, Kaufmann F, Rolli H et al. (2005a) A fast and flexible PEG-mediated transient expression system in plants for high level expression of secreted recombinant proteins. J Biotechnol 119:332-342
6. Baur A, Reski R, Gorr G, (2005b) Enhanced recovery of a secreted recombinant human growth factor using stabilizing additives and by co-expression of human serum albumin in the moss Physcomitrella patens. Plant Biotechnol J 3:331-340
7. Bendich AJ (1987) Why do chloroplast and mitochondria contain so many copies of their genome?. BioEssays 6:279-282
8. Boothe JG, Parmenter DL, Saponja JA (1997) Molecular farming in plants: oilseeds as vehicles for the production of pharmaceutical proteins. Drug Develop Res 42:172-181
9. Borisjuk NV, Borisjuk LG, Logendra S et al. (1999) Production of recombinant proteins in plant root exudates. Nature Biotech 17:466-469
10. Canizares MC, Nicholson L, Lomonossoff GP (2005) Use of viral vectors for vaccine production in plants. Immunol Cell Biol 83:263-270
11. Chikwamba R, Cunnick J, Hathaway D et al. (2002) A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT). Transgenic Res 11:479-493
12. Clendennen SK, Lopez-Gomez R, Gomez-Lim M et al. (1998) The abundant 31-kilodalton banana pulp protein is homologous to class III acidic chitinases. Phytochemistry 47:613-619
13. Conneely OM, Headon DR, O'Malley BW et al. (2001) Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms, US Patent 6, 228, 614, 2001
14. Cramer CL, Boothe JG, Oishi KK (1999) Transgenic plants for therapeutic proteins: Linking up stream and down stream strategies, In: Hammond J, McGarvey P, Yusibov V, (ed) Current topics Microbiology and Immunology, Plant biotechnology: New products and applications. Springer-Verlag, Berlin, p 95-118
15. Cramer CL, Weissenborn DL, (1997) HMG2 promoter expression system and post harvest production of gene products in plants and plant cell cultures. US patent No. 5, 670, 349, 1997
16. Cramer CL, Weissenborn DL, Oishi KK et al. (1996) High level production of enzymatically active human lysosomal proteins in transgenic plants. In: Owen MRL, Pen J, (ed) Transgenic plants: A production system for industrial and pharmaceutical protein. Wiley, Chichester, p 299-310
17. Daniell H, Guda C, McPherson DT et al. (1996) Hyper expression of a synthetic protein-based polymer gene. Meth Mol Biol 63:359-371
18. Daniell H, Khan MS, Allison L (2002) Milestones in chloroplast genetic engineering: an environmentally friendly era in biotechnology. Trends Plant Sci 7:84-91
19. Daniell H, Streatfield SJ, Wycoff K, (2001) Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. TIPS 6:219-226
20. De Cosa B, Moar W, Lee SB et al. (2001) Hyper-expression of the Bt Cry-2 Aa2 operon in chloroplast leads to formation of insecticidal crystals. Nature Biotechnol 19:71-74
21. Delaney DE (2002) Choice of crop species and development of transgenic product lines. In: Hood EE, Howard JA, (ed) Plants as factories for protein production. Kluwer, Dordrecht, p 139-158
22. Delaney D, Jilka J, Barker D et al. (2002) Production of aprotinin in transgenic maize seeds for the pharmaceutical and cell culture markets. In: Vasil IK, (ed) Plant biotechnology 2002 and beyond. Kluwer, Dordrecht, p 393-394
23. De Zoeten GA, Penwick JR, Horisberger MA et al. (1989) The expression, localization and effect of a human interferon in plants. Virology 172:213-222
24. Dieryck W, Pagnier J, Poyart C et al. (1997) Human hemoglobin from transgenic tobacco. Nature 386:29-30
25. Dogan B, Mason HS, Richter L et al. (2000) Process options in hepatitis B surface antigen extraction from transgenic potato. Biotechnol Prog 16:435-441
26. Douce G, Giuliani MM, Giannelli V et al. (1998) Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli. Vaccine 16:1065-1073
27. During K (1988) Wound-inducible expression and secretion of T4 lysozyme and monoclonal antibodies in Nicotiana tabacum. Ph. D Thesis. Mathematish-Naturwissenschaftlichen Fakultaet der Universitaet Zu Koeln
28. Edelbaum O, Stein D, Holland N et al. (1992) Expression of active human interferon in transgenic plants. J Interferon Res 12:449-453
29. Elliott S, Lorenzini T, Asher S et al. (2003) Enhancement of therapeutic protein in vivo activities through glycoengineering. Nature Biotechnol 21:414-421
30. Evangelista RL, Kusnadi AR, Howard JA et al. (1998) Process and economic evaluation of the extraction and purification of recombinant β-glucuronidase from transgenic corn. Biotechnol Prog 14:607-614
31. Fiedler U, Conrad U (1995) High-level production and long term storage of engineered antibodies in transgenic tobacco seeds. Biotechnology 13:1090-1093
32. Fiedler U, Phillips J, Artsaenko O et al. (1997) Optimization of ScFv production in transgenic plants. Immunotechnology 3:205-216
33. Fischer R, Emans N (2000) Molecular farming of pharmaceutical proteins. Transgenic Res 9:279-299
34. Fischoff DA (1992) Field performance of insect resistant crops. J Cell Biochem Suppl 16F:199
35. Fraley RT, Rogers SG, Horsch RB et al. (1983) Expression of bacterial genes in plant cells. Proc Natl Acad Sci USA 80:4803-4807
36. Franken E, Teuschel U, Hain R (1997) Recombinant proteins from transgenic plants. Curr Opin Biotechnol 8:411-416
37. Franklin SE, Mayfield SP (2004) Prospects for molecular farming in the green alga Chlamydomonas reinhardtii. Curr Opin Plant Biol 7:159-165
38. Freytag LC, Clements JD (2004) Mucosal adjuvants. Vaccine 23:1804-1813
39. Ganz PR, Dudani AK, Tackaberry ES et al. (1996) Expression of human blood proteins in transgenic plants: The cytokine GM-CSF as a model protein. In: Owen MRL, Pen J (ed) Transgenic plants: A production system for industrial and pharmaceutical proteins. John Wiley and Sons, London, UK, p281-297
40. Gaume A, Komarnytsky S, Borisjuk N et al. (2003) Rhizosecretion of recombinant proteins from plant hairy roots. Plant Cell Rep 21:1188-1193
41. Gleba Y, Klimyuk V, Marillonnet S (2005) Magnifection - a new platform for expressing recombinant vaccines in plants. Vaccine 23:2042-2048
42. Gomord V, Chamberlain P, Jefferis R et al. (2005) Biopharmaceuticals production in plants: problems, solutions and opportunities. TIBTECH 23:559-565
43. Gomord V, Denmat LA, Fitchette-Laine AC et al. (1997) The C-terminal HDEL sequence is sufficient for retention of secretory proteins in the endoplasmic reticulum (ER) but promotes vacuolar targeting of proteins that escape the ER. Plant J 11:313-325
44. Gomord V, Sourrouille C, Fitchette AC et al. (2004) Production and glycosylation of Plant-made pharmaceuticals: the antibodies as a challenge. Plant Biotechnol J 2:83-100
45. Gorr G, Jost W (2005) Glycosylation design in transgenic moss for better product efficacy. BioProcessing J 4:26-30
46. Grevich JJ, Daniell H (2005) Chloroplast genetic engineering: Recent advances and future perspectives. Critical Rev Plant Sci 24:83-107
47. Gruber V, Berna PP, Arnaud T et al. (2001) Large-scale production of a therapeutic protein in transgenic tobacco plants: effect of subcellular targeting on quality of a recombinant dog gastric lipase. Mol Breed 7:329-340
48. Hamamoto H, Sugiyama Y, Nakagawa N et al. (1993) A new tobacco mosaic virus vector and its use for the systemic production of angiotensin-1 converting enzyme inhibitor in transgenic tobacco and tomato. Biotechnology 11:930-932
49. Haq TA, Mason HS, Clements JD et al. (1995) Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268:714-716
50. Herbers K, Wilke I, Sonnewald U (1995) A thermostable xylanase from Closteridium thermocellum expressed at high levels in the apoplast of transgenic tobacco has no detrimental effects and is easily purified. Biotechnology 13:63-66
51. Hiatt A, Cafferkey R, Bowdish K (1989) Production of antibodies in transgenic plants. Nature 342:76-78
52. Higo K, Saito Y, Higo H, (1993) Expression of a chemically synthesized gene for human epidermal growth factor under the control of cauliflower mosaic virus 35S promoter in transgenic tobacco. Biosci Biotech Biochem 57:1477-1481
53. Hood EE, Witcher DR, Maddock S et al. (1997) Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification. Mol Breed 3:291-306
54. Hood EE, Woodard SL, Horn ME (2002) Monoclonal antibody manufacturing in transgenic plants-myths and realities. Curr Opin Biotechnol 13:630-635
55. Horn ME, Pappu KM, Bailey MR et al. (2004) Advantageous features of plant based systems for the development of HIV vaccines. J Drug Targeting 11:539-545
56. Huang Z, Santi L, LePore K et al. (2006) Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice. Vaccine 24:2506-2513
57. Huether CM, Lienhart O, Baur A et al. (2005) Glyco-engineering of moss lacking plant-specific sugar residues. Plant Biol 7:292-299
58. Imani J, Berting A, Nitsche S et al. (2002) The integration of a major hepatitis B virus gene into cell-cycle synchronized carrot cell suspension cultures and its expression in regenerated carrot plants. Plant Cell Tissue Org Cult 71:157-164
59. James EA, Wang C, Wang Z et al. (2000) Production and characterization of biologically active human GM-CSF secreted by genetically modified plant cells. Prot Expr Purif 19:131-138
60. Jefferson RA, Kavanaugh TA, Bevan MW (1987) GUS fusion: β-glucuronidase as a sensitive and versatile gene fusion marker in higher plants. EMBO J 6:3901-3907
61. Jilka J (1999) Have your vaccine and eat it too. In: Global Agbiotech progress Proceedings of the AgBiotech World Forum '99, Global AG BioTech Progress, Drug and Market Development Publications, p 89-95
62. Jost W, Link S, Horstmann V et al. (2005) Isolation and characterization of three moss-derived betatubulin promoters suitable for recombinant expression. Curr Genet 47:111-120
63. Joung YH, Youm JW, Jeon JH (2004), Expression of the hepatitis B surface S and pre S2 antigens in tubers of Solanum tuberosum. Plant Cell Rep 22:925-930
64. Kang TJ, Han SC, Kim MY et al. (2004) Expression of non-toxic mutant of Escherichia coli heat-labile enterotoxin in tobacco chloroplasts. Protein Expr Purif 38:123-128
65. Kapila J, De Rycke R, van Montagu M et al. (1996) An Agrobacterium mediated transient expression system for intact leaves. Plant Sci 122:101-108
66. Kapusta J, Modelska A, Figlerowicz M et al. (1999) A plant derived edible vaccine against hepatitis B virus. FASEB J 13:1796-1799
67. Khoudi H, Laberge S, Ferullo JM et al. (1999) Production of a diagnostic monoclonal antibody in perennial alfalfa plants. Biotechnol. Bioeng 64:135-143
68. Ko K, Tekoah Y, Rudd PM et al. (2003) Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc Natl Acad Sci USA 10:8013-8018
69. Komarnytsky S, Borisjuk NV, Borisjuk LG et al. (2000) Production of recombinant proteins in tobacco guttation fluid. Plant Physiol 124:927-933
70. Kong Q, Richter L, Yang YF et al. (2001) Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc Natl Acad Sci USA 98:11539-11544
71. Koprivova A, Altmann F, Gorr G et al. (2003) N-glycosylation in the moss Physcomitrella patens is organized similarly to higher plants. Plant Biol 5:582-591
72. Kumagai MH, Turpen TH, Weinzettl N et al. (1993) Rapid, high level expression of biologically active alpha-trichosanthin in transfected plant by an RNA viral vector. Proc Natl Acad Sci USA 90:427-430
73. Kusnadi AR, Hood EE, Witcher DR et al. (1998) Production and purification of two recombinant proteins from transgenic corn. Biotech Prog 14:149-155
74. Kusnadi AR, Niklov ZL, Howard JA (1997) Production of recombinant proteins in transgenic plants: Practical considerations. Biotech Bioeng 56:473-484
75. Larrick JW, Yu L, Naftzger C et al. (2001) Production of secretory IgA antibodies in plants. Biomol Engg 18:87-94
76. Lauterslager TGM, Florack DEA, van der Wal TJ et al. (2001) Oral immunization of naïve and primed animals with transgenic potato tubers expressing LT-B. Vaccine 19:2749-2755
77. Legrand D, Salmon V, Spoik G et al. (2003) Recombinant lactoferrin, methods of production from plants and uses. US Patent 6 569 831
78. Magnuson NS, Linzmaier PM, Reeves R et al. (1998) Secretion of biologically active human interleukin-2 and interleukin-4 from genetically modified tobacco cells in suspension culture. Prot Exp Purif 13:45-52
79. Masarik M, Kizek R, Kramer KJ et al. (2003) Application of avidin-biotin technology and adsorptive transfer tripping square-wave voltammetry for detection of DNA hybridization and avidin maize. Anal Chem 75:2663-2669
80. Mason HS, Haq TA, Clements JD et al. (1998) Edible vaccine protects mice against Escherichia coli heat-labile enterotoxine (LT): potatoes expressing a synthetic LT-B gene. Vaccine 16:1336-1343
81. Mason HS, Lam DMK, Arntzen CJ (1992) Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci USA 89:11745-11749
82. Matsumoto S, Ikura K, Ueda M et al. (1995) Characterization of a human glycoprotein (erythropoietin) produced in cultured tobacco cells. Pant Mol Biol 27:1163-1172
83. Mitchell VS, Philipose MM, Sanford JP (ed) (1993) The children's vaccine initiative: achieving the vision, National Academy Press. p 23
84. Mitra A, Zhang Z (1994) Expression of a human lactoferrin cDNA in tobacco cells produces antibacterial protein (s). Plant Physiol 106:997-981.
85. Molowa D, Schenouda M, Meyers A et al. (2002) The state of biologics manufacturing part II J. P. Morgan Market analysis of the state of manufacturing of biologics including mAbs. p 1-16
86. Muntz K (1998) Deposition of storage proteins. Deposition of storage proteins, Plant Mol Biol 38:77-99
87. Nandi S, Suzuki YA, Huang J et al. (2002) Expression of human lactoferrin in transgenic rice grains for the application in infant formula. Plant Sci 163:713-722
88. Newman T, Ohme-Takagi M, Taylor C et al. (1993) DST sequences, highly conserved among plant SAUR genes, target reporter transcripts for rapid decay in tobacco. Plant Cell 5:701-714
89. Nikolov Z, Hammes D (2002) Production of recombinant proteins from transgenic crops, In: Hood EE, Howard J (ed) Plants as Factories for Protein Production. Kluwer Academic Publishers, Dordrecht, p 159-174
90. Palacpac NQ, Yoshida S, Sakai H et al. (1999) Stable expression of human 1, 4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. Proc Natl Acad Sci USA 96:4692-4697
91. Pen J, Sijmons PC, van Ooijen AJJ et al. (1993) Protein production in transgenic crops: analysis of plant molecular farming. In: Hiatt A (ed) Transgenic plants fundamentals and applications. Marcell Dekker, NY, p 239-254
92. Peng J, Song Q, Chengkui T (2002) Expression of hepatitis B surface antigen gene (HBsAg) in Laminaria japonica (Laminariales, Phaeophyta). Chinese Sci Bullt 47:1438-1440
93. Peumans WJ, Proost P, Swennen RL et al. (2002) The abundant class III chitinase homolog in young developing banana fruits behaves as a transient vegetative storage protein and most probably serves as an important supply of aminoacids for the synthesis of ripening-associated proteins. Plant Physiol 130:1063-1072
94. Rappuoli R, Pizza M, Douce G et al. (1999) Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. Immunol Today 20:493-500
95. Richter L, Kipp PB (1999) Transgenic plants as edible vaccines. In: Hammond J, McGarvey P, Yusibov V (ed) Plant biotechnology-new products and applications. Springer-Verlag, New York, p159-176
96. Richter LJ, Thanavala Y, Arntzen CJ et al. (2000) Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nature Biotechnol 18:1167-1171
97. Ruggiero F, Exposito JY, Bournat P et al. (2000) Triple helix assembly and processing of human collagen produced in transgenic tobacco plants. FEBS Lett 469:132-136
98. Rymerson RT, Menassa R, Brandle JE (2002) Tobacco, a platform for the production of recombinant proteins. In: Erickson L, Yu WJ, Brandle J, Rymerson R (ed) Molecular farming of plants and animals for human and veterinary medicine. Kluwer Academic Publishers, Netherlands, p1-31
99. Salmon V, Legrand D, Slomianny MC et al. (1998) Production of human lactoferrin in transgenic tobacco plants. Prot Expr Purif 13:127-135
100. Samyn-Petit B, Gruber V, Flahaut C et al. (2001) N-Glycosylation potential of maize: the human lactoferrin used as a model. Glycoconjugate J 18:519-527
101. Sandhu JS, Osadjan MD, Krasnyanski SF et al. (1999) Enhanced expression of the human respiratory syncytial virus: F gene in apple leaf protoplast. Plant Cell Rep 18:394-397
102. Santi L, Giritch A, Roy CJ et al. (2006) Protection conferred by recombinant Yersinia pestis antigen produced by a rapid and highly scalable plant expression system. Proc Natl Acad Sci USA 103:861-866
103. Schouten A, Roosien J, Van Engelen FA et al. (1996) The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco. Plant Mol Biol 30:781-793
104. Shanks JV, Morgan J (1999) Plant 'hairy root' culture. Curr Opin Biotechnol 10:151-155
105. Sijmons PC, Dekker BMM, Schrammeijer B et al. (1990) Production of correctly processed human serum albumin in transgenic plants. Biotechnology 8:217-221
106. Smirnov SP, Teveroskaia EKH, Krasheninnikova LV et al. (1990) Design of an expression integrative vector and its application for introducing the human recombinant-interferon gene into plants. Genetika 26:2111-2121
107. Smith ML, Keegan ME, Mason HS et al. (2002a) Factors Important in the Extraction, Stability and in vitro assembly of the hepatitis B surface antigen derived from recombinant plant systems. Biotechnol Prog 18:538-550
108. Smith ML, Mason HS, Schuler ML (2002b) Hepatitis B surface antigen (HBsAg) expression in plant cell culture: kinetics of antigen accumulation in batch culture and its intracellular form. Biotech Bioeng 80:812-822
109. Smith ML, Richter L, Arntzen CJ et al. (2003) Structural characterization of plant derived hepatitis B surface antigen employed in oral immunization studies. Vaccine 21:4011-4021
110. Sojikul P, Buehner N, Mason HS (2003) A plant signal peptide-hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells. Proc Nat Acd Sci USA 100:2209-2214
111. Sriraman R, Bardor M, Sack M et al. (2004) Recombinant anti-hCG antibodies retained in the endoplasmic reticulum of transformed plants lack core-xylose and core-cx (1, 3)-fucose residues. Plant Biotechnol J 2:279-288
112. Staub JM, Garcia B, Graves J et al. (2000) High yield production of a human therapeutic protein in tobacco chloroplasts. Nat Biotechnol 18:333-338
113. Stevens LH, Stoopen GM, Elbers IJ et al. (2000) Effect of climate conditions and plant developmental stage on the stability of antibodies expressed in transgenic tobacco. Plant Physiol 124:173-182
114. Stoger E, Ma JK, Fischer R et al. (2005) Sowing the seeds of success: pharamaceutical proteins from plants. Curr Opin Biotechnol 16:1-7
115. Streatfeld SJ, Meyer JM, Barker DK et al. (2002) Development of an edible subunit vaccine in corn against enterotoxigenic strains of Escherichia coli. In Vitro Cell Dev Biol Plant 38:11-17
116. Streatfield SJ (2005) Oral hepatitis B vaccine candidates produced and delivered in plant material. Immunol Cell Biol 83:257-262
117. Sunil Kumar GB, Ganapathi TR, Bapat VA, (2004) Edible vaccines: Current Status and Future Prospects. Physiol Mol Biol Plants 10:37-47
118. Sunil Kumar GB, Ganapathi TR, Revathi CJ et al. (2003) Expression of hepatitis B surface antigen in tobacco cell suspension cultures. Prot. Expr. Purif. 32:10-17
119. Sunil Kumar GB, Ganapathi TR, Revathi CJ et al. (2005b) Expression of hepatitis B surface antigen in transgenic banana plants. Planta 222:484-493
120. Sunil Kumar GB, Ganapathi TR, Srinivas L et al. (2005a) Secretion of hepatitis B surface antigen in transformed tobacco cell suspension cultures. Biotechnol Lett 27:927-932
121. Sunil Kumar GB, Ganapathi TR, Srinivas L et al. (2006b) Expression of hepatitis B surface antigen in potato hairy roots. Plant Sci 170:918-925
122. Sunil Kumar GB, Srinivas L, Ganapathi TR et al. (2006a) Hepatitis B surface antigen expression in transgenic tobacco (Nicotiana tabacum) plants using four different expression cassettes. Plant Cell Tissue Org Cult 84:315-323
123. Sutton DW, Havstad PK, Kemp JD (1992) Synthetic cryIIIA gene from Bacillus thuringiensis improved for high expression in plants. Transgenic Res 1:228-236
124. Tackaberry ES, Dudani AK, Prior F et al. (1999) Development of biopharmaceuticals in plant expression systems: Cloning, expression and immunological reactivity of cytomegalovirus glycoprotein B (UL55) in seeds of transgenic tobacco. Vaccine 17:3020-3029
125. Takase, K, Hagiwara K (1998) Expression of human alpha-lactalbumin in transgenic tobacco. J Biochem 123:440-444
126. Taylor C, Green P (1995) Identification and characterization of genes with unstable transcripts (GUTS) in tobacco. Plant Mol Biol 28:27-38
127. Thanavala Y, Mahoney M, Pal S et al. (2005) Immunogenicity in humans of an edible vaccine for hepatitis B. Proc Natl Acad Sci USA 102:3378-3382
128. Thanavala Y, Yang YF, Lyons P et al. (1995) Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc Natl Acad Sci USA 92:3358-3361
129. Twyman RM, Schillberg S, Fischer R (2005) Transgenic plants in the biopharmaceutical market. Expert Opin Emerging Drugs 10:185-218
130. Twyman RM, Stoger E, Schillberg S et al. (2003) Molecular farming in plants: host systems and expression technology. TIBTECH 21:570-578
131. Van den Akker F, Pizza M, Rappuoli R et al. (1997) Crystal structure of a non-toxic mutant of heat labile enterotoxin, which is a potent mucosal adjuvant. Protein Sci 6:2650-2654
132. van Rooijen GJH, Moloney MM (1995) Structural requirements of oleosin domains for the subcellular targeting to the oil body. Plant Physiol 109:1353-1361
133. Vandekerckhove J, Damme VJ, van Lijsebettens M et al. (1989) Enkephalins produced in transgenic plants using modified 2S seed storage proteins. Biotechnology 7:929-932
134. Vaquero C, Sack M, Chandler J et al. (1999) Transient expression of a tumor specific single chain fragment and a chimeric antibody in tobacco leaves. Proc Natl Acad Sci USA 96:11128-11133
135. von Schaewen A, Sturm A, O'Neill J et al. (1993) Isolation of a mutant Arabidopsis plant that lacks N-acetylglucosaminyltransferase 1 is unable to synthesize golgi modified complex N-linked glycans. Plant Physiol 102:1109-1118
136. Wenderoth I, von Schaewen A (2000) Isolation and characterization of plant N-acetyl glucosaminyltransferase I (GntI) cDNA sequences. Functional analyses in the Arabidopsis cgl mutant and in antisense plants. Plant Physiol 123:1097-1108
137. Watson J, Koya V, Leppla SH et al. (2004) Expression of Bacillus anthracis protective antigen in transgenic chloroplasts of tobacco, a non-food/feed crop. Vaccine 22:4374-4384
138. WHO/Unicef/The World Bank. State of the world's vaccines and immunization 2002. Geneva: World Health Organization Department of Vaccines and Biologicals, 2002.
139. Witcher DR, Hood EE, Petersen D et al. (1998) Commercial production of β-glucuronidase (GUS): a model system for the production of proteins in plants. Mol Breed 4:301-312
140. Woodard SL, Mayor JM, Bailey MR et al. (2003) Maize-derived bovine trypsin: characterization of the first large-scale commercial protein product from transgenic plants. Biotechnol Appl Biochem 38:123-130
141. Woodleif WG, Chaplin JF, Campbell CR et al. (1981) Effect of variety and harvest treatments on protein yield of close grown tobacco. Tob Sci 25:83-86
142. Wright A, Morrison SL (1998) Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells. J Immunol 160:3393-3402
143. Zeitlin L, Olmsted SS, Moench TR et al. (1998) A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes. Nat Biotechnol 16:1361-1364
144. Zhong GY, Peterson D, Delaney DE et al. (1999) Commercial production of aprotinin in transgenic maize seeds Mol Breed 5:345-356